The cost of Perjeta (pertuzumab) drug treatment for Australians who have breast cancer
Patients suffering from HER2-positive metastatic breast cancer can now look for hope when treated with the drug Perjeta (pertuzumab). The new drug is recommended for use in conjunction with trastuzumab and docetaxel for addressing this condition. Those patients who have not received any anti HER2 […]